Bank of Kentucky’s AbbVie ABBV Stock Holding History

Bank of Kentucky’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$9.53M	Sell	162,792 -6,795	-4%	-$411K	2.2%	15
2014 Q4	$11.1M	Sell	169,587 -3,140	-2%	-$198K	2.4%	9
2014 Q3	$9.98M	Buy	172,727 +550	+0.3%	+$30.5K	2.2%	13
2014 Q2	$9.72M	Sell	172,177 -2,505	-1%	-$131K	2.16%	11
2014 Q1	$8.98M	Buy	174,682 +26,775	+18%	+$1.35M	2.04%	19
2013 Q4	$7.81M	Buy	147,907 +12,600	+9%	+$619K	2.03%	18
2013 Q3	$6.05M	Buy	135,307 +7,354	+6%	+$326K	1.74%	27
2013 Q2	$5.29M	Buy	+127,953	New	+$5.6M	1.62%	29

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of Kentucky's ABBV Position: Q1 2015 in Review

Bank of Kentucky reduced its AbbVie (ABBV) stake by 4% in Q1 2015, selling an estimated $411K and leaving 162,792 shares worth $9.53M. The position accounts for 2.2% of the portfolio, ranked #15.

Bank of Kentucky first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $11.1M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Bank of Kentucky held 162,792 shares of AbbVie worth $9.53M as of Q1 2015.
Bank of Kentucky sold 6,795 AbbVie shares in Q1 2015, an estimated $411K.
AbbVie made up 2.2% of Bank of Kentucky's portfolio in Q1 2015, its #15 holding.
Bank of Kentucky first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
Bank of Kentucky's AbbVie position peaked at $11.1M in Q4 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.